This month’s healthcare news highlights public health governance updates involving the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC), as well as trade restrictions affecting medical technology advancements. These events carry notable implications for the health and pharmaceutical sectors. To support informed decision-making, Fullintel Hub provides expert insights, in-depth […]
